Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...
Sagimet Biosciences dropped 9% after Ascletis Pharma’s Phase 3 Denifanstat safety data focused on tolerability, not new ...
New research shows how some brain cells fight tau buildup in Alzheimer’s, pointing to internal systems that help neurons survive longer.
Cells operate on rules not vibes, including when on the precipice of persisting or perishing. Yet, with prior research ...
Researchers are continually looking for new ways to hack the cellular machinery of microbes like yeast and bacteria to make ...
Bacteria can be turned into living factories that churn out complex molecules using reactions catalysed by light 1.
The Law of Mass action predicts that all adverse drug reactions are related to the concentration of the drug at the site of ...
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results